Clinical trial for new drug registration in China 2021

Contact us for full report

In 2021, the number of drug clinical trials registered in China exceeded 3000 for the first time, with a total of 3358 clinical trials registered. The clinical trials of new drugs were still dominated by chemical drugs, accounting for 70.8%; The second is biological products, accounting for 26.7%.

A total of 68 trials were registered in the top 10 varieties of clinical trials of chemical drugs, and Mitoxantrone Hydrochloride liposome injection had the largest number of trials, 9. 104 trials were registered in the top 10 varieties of biological products for clinical trials, mainly for therapeutic biological products, involving 10 varieties and 75 trials (72.1%); The prophylactic biological products involved 29 trials (27.9%) of 2 varieties, all of which were novel coronavirus vaccines. The number of clinical trials of novel coronavirus inactivated vaccine (Vero cell) was the largest, with 20 items.